
1Crowd backs Rymo Technologies for robotic rehabilitation
Photo: Rymo, official Mobi-L product image. Product photograph, not a treatment-outcome illustration.1Crowd has invested in Rymo Technologies, an Indian company building robotic systems for physical rehabilitation. The investment was announced on November 12. Financial terms, valuation and a named funding round were not disclosed. This announcement is separate from earlier reported financing.
Rymo develops equipment used by clinicians treating neurological and orthopaedic conditions. Robotic rehabilitation means using controlled mechanical assistance or resistance to help a patient practise movements, while measuring the exercise. The machines support physiotherapy rather than replacing the clinician.
Its Mobi-L product is a portable multi-limb rehabilitation device. The company describes more than 20 exercises across more than seven joint protocols, with attachments for different movements. Training modes range from assisted movement to resistance, allowing a physiotherapist to adjust the exercise to the patient.
The product also records range of motion, strength, speed and reaction time. These measurements can help clinicians track a session and adjust treatment. Games and virtual-reality tasks are intended to keep patients engaged in repeated exercises; they are product features, not proof of better clinical outcomes.
Rymo also lists balance trainers and extended-reality rehabilitation systems in its portfolio. The financing announcement describes functional electrical stimulation devices as upcoming. Such devices use electrical pulses to stimulate muscle movement. They are planned products, rather than confirmed deployments.
Affordability is central to the company and investor's account of the business. Their announcement says Rymo's products cost around 10-20% of foreign alternatives, aimed at smaller hospitals and physiotherapy clinics as well as larger facilities. That is a company claim, not an independently tested price comparison. The announcement gives no detailed allocation of the new investment.
DTT summary based on BusinessLine's report. The full article is on the publisher's site.
Additional reporting
1Crowd investment announced November 12; amount, valuation and round name undisclosed.
Mobi-L multi-limb rehabilitation, balance trainers and XR therapy systems.
Hospitals, physiotherapy clinics and rehabilitation centres.
Clinician-directed equipment; no independent clinical-outcome claim inferred.
Investor and company affordability statements are claims, not independently tested price or outcome comparisons.